90 FR 116 pgs. 26069-26070 - Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem
Type: NOTICEVolume: 90Number: 116Pages: 26069 - 26070
Pages: 26069, 26070Docket number: [Docket No. DEA-1558]
FR document: [FR Doc. 2025-11247 Filed 6-17-25; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1558]
Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
American Radiolabeled Chem has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on, or before August 18, 2025. Such persons may also file a written request for a hearing on the application on or before August 18, 2025.
ADDRESSES:
[top] The Drug Enforcement Administration requires that all comments be submitted electronically
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on April 16, 2025, American Radiolabeled Chem, 101 Arc Drive, Saint Louis, Missouri 63146-3502, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):
Controlled substance | Drug code | Schedule |
---|---|---|
Gamma Hydroxybutyric Acid | 2010 | I |
Ibogaine | 7260 | I |
Lysergic acid diethylamide | 7315 | I |
Tetrahydrocannabinols | 7370 | I |
Dimethyltryptamine | 7435 | I |
1-[1-(2-Thienyl)cyclohexyl]piperidine | 7470 | I |
Dihydromorphone | 9145 | I |
Heroin | 9200 | I |
Normorphine | 9313 | I |
Amphetamine | 1100 | II |
Methamphetamine | 1105 | II |
Amobarbital | 2125 | II |
Phencyclidine | 7471 | II |
Phenylacetone | 8501 | II |
Cocaine | 9041 | II |
Codeine | 9050 | II |
Dihydrocodeine | 9120 | II |
Oxycodone | 9143 | II |
Hydromorphone | 9150 | II |
Ecgonine | 9180 | II |
Hydrocodone | 9193 | II |
Meperidine | 9230 | II |
Metazocine | 9240 | II |
Methadone | 9250 | II |
Dextropropoxyphene, bulk (non-dosage forms) | 9273 | II |
Morphine | 9300 | II |
Oripavine | 9330 | II |
Thebaine | 9333 | II |
Oxymorphone | 9652 | II |
Phenazocine | 9715 | II |
Carfentanil | 9743 | II |
Fentanyl | 9801 | II |
The company plans to bulk manufacture the listed controlled substances for internal use as intermediates or for sale to its customers. The company plans to manufacture small quantities of the above listed controlled substances as radiolabeled compounds for biochemical research. In reference to drug code 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-11247 Filed 6-17-25; 8:45 am]
BILLING CODE 4410-09-P